Genmab — November 2020
-
-
Tror GS startede opkøb i går - men omsætningen var for lav og kursen steg for hurtigt
-
GS har opkøbt et stykke tid. Har vel omkring 1,5% af Genmab aktierne jf Morningstar http://investors.morningstar.com/ownership/shareholders-major.html?t=GNMSF
-
Ved du hvilke dato forrige portefølje er opgjort? De har forøget sin beholdning med 84 % i indeværende vindue.
-
Ok tak. Skal huske den oversigt fremadrettet. GS må tro på sagen med den forøgelse.
-
NICE sagde ja, Medicinrådet nej https://www.nice.org.uk/news/article/new-option-for-people-with-difficult-to-treat-multiple-myeloma-is-recommended-for-use-in-cancer-drugs-fund-by-nice https://haematologisktidsskrift.dk/sygdomme/myeloma/769-tommelfingeren-nedad-til-isatuximab-i-tredje-linje-ved-myelomatose.html
-
Stoxx: Europæiske health care aktier gør forsøg på positivt udbrudhttps://www.proinvestor.com/investornyt/669894/stoxx-europaeiske-health-care-aktier-gor-forsog-pa-positivt-udbrud
-
Det vil ikke være så ring
enda... på godt nordjysk..:-D -
-
Greed is good
-
Tak Pensionist.
-
Om at bruge Fear/greed-indekset. https://www.proinvestor.com/boards/88858
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind